Liraglutide (Saxenda): The Original Weight Loss GLP-1 Liraglutide was the first GLP-1 receptor agonist to receive FDA approval specifically for chronic weight management, doing so in 2014 under the brand name Saxenda
Your health is a partnership, and together we can support your goals through transparency, quality, and dedication to wellness
In the evolving landscape of weight management and metabolic health, two innovative treatment combinations have gained significant attention: Semaglutide and Tirzepatide
The needles used are very small, and the injections themselves only take a few minutes
By now, youve learned about the impressive healing potential tied to the BPC-157 mechanism of action
However, high risk patients (advanced PD, diabetic patients, subclinical PN) who are considered as more prone to developing symptomatic PN should receive regular injections of Vit B12 and B6 (Uncini et al